Baylis Medical Technologies Launches the PowerWire® 14 RF Guidewire
In a significant advancement for the medical device industry, Baylis Medical Technologies Inc. has unveiled the PowerWire® 14 Radiofrequency (RF) Guidewire. This innovative device has recently gained U.S. FDA 510(k) clearance and is now commercially available, representing a pivotal moment in the facilitation of vascular procedures.
The PowerWire® 14 is the first RF-enabled crossing wire with a diameter of just 0.014 inches, designed specifically for navigating and treating completely occluded native or stented peripheral vessels that are 3mm or larger. Its smaller profile offers healthcare professionals a customizable option for challenging cases where precision is critical.
As physicians around the world tackle complex occlusions, the PowerWire® 14 RF Guidewire stands out. By building on the established platform of the PowerWire® Pro RF Guidewire, Baylis has successfully integrated a cutting-edge RF-assisted crossing capability with a remarkably slim design. This combination is essential for clinicians managing intricate anatomies where significant control is necessary.
Unique Features and Advantages
Early feedback from physicians who have utilized the PowerWire® 14 suggests notable advantages, particularly in high-pressure environments and complex anatomical structures. The guidewire's slim design provides enhanced comfort for doctors, allowing them to perform procedures with greater confidence.
One of the defining characteristics of the PowerWire® 14 is its energized tip that automatically terminates RF delivery upon contact with metal. This safety feature is especially useful in managing challenging in-stent occlusions and aids in maintaining controlled advancement throughout the procedure.
Laura Conquergood, CEO of Baylis Medical Technologies, expressed her excitement regarding the launch, stating, "The introduction of the PowerWire® 14 RF Guidewire expands our RF puncture crossing portfolio with a 0.014 inch option, providing physicians with additional flexibility to select the wire profile that best aligns with vessel size, lesion characteristics, and procedural approach." Her statement underscores Baylis's commitment to enhancing procedural outcomes through innovative technology.
A Commitment to Improving Patient Outcomes
Baylis Medical Technologies has a strong legacy, striving to enhance patient care through the development and commercialization of state-of-the-art medical devices. This new guidewire aligns perfectly with the company's mission to improve patient outcomes in cardiovascular and other medical scenarios.
As healthcare professionals increasingly turn to RF technologies to aid in complex vascular treatments, the introduction of the PowerWire® 14 RF Guidewire marks a pivotal evolution in their toolkit. The ability to customize wire profiles to fit specific vascular conditions allows for more tailored treatment options, potentially leading to better recovery times and improved success rates in procedures.
For additional details on the PowerWire® 14 RF Guidewire and the rest of the PowerWire® family of RF Guidewires, healthcare professionals are encouraged to visit
Baylis's official website. For inquiries, they can also reach out via email at
[email protected] or by calling 1-888-505-4885.
In conclusion, the launch of the PowerWire® 14 signifies a noteworthy step forward in the vascular treatment landscape, empowering medical professionals with cutting-edge tools to tackle complex cases with enhanced accuracy and safety. The combination of Baylis Medical Technologies' innovation and the dedication of healthcare providers is set to elevate the standard of care for patients around the world.